semaglutide dulaglutide GI risks similar between dulaglutide, tirzepatide and Comparison of the injection‐site experience

purchasing it from unregulated sources carries serious patient safety risks

PCSK9, proprotein convertase subtilisin/kexin type 9

We use pharmaceutical-grade ingredients and follow strict safety protocols to minimize any risks

The goal of this procedure is to preserve healthy cells while eliminating senescent cells

weight loss at target dose (trial data) ~6% CV risk reduction labelled Yes (T2D + CVD) Format Prefilled FlexTouch pen India price (May 2026) 5,6609,100/month DCGI-approved Yes (pre-2026) Generic competition in India n/a (innovator) Wegovy Novo Nordisk semaglutide Active molecule Semaglutide Receptor activity GLP-1 Primary indication Chronic weight management Max maintenance dose 2.4 mg weekly Avg

During your consultation, we will speak with you to discuss your overall aesthetic goals and develop a treatment plan with your provider